NCT06949137View on ClinicalTrials.gov

Intravenous Infusion of hMSC100 (hUC-MSC) in Postmenopausal Women With Osteoporosis at High Risk of Fracture

PHASE1RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions

Osteoporosis in Post-menopausal WomenOsteoporosis

Interventions

BIOLOGICAL

Human Umbilical Cord-derived Mesenchymal stem cell

Intravenous infusion of hMSC100 at 20-25 drops per minute

Trial Locations (1)

210000

RECRUITING

HelpThera, Nanjing

Sponsors

Lead Sponsor

Help Therapeutics

All Listed Sponsors

collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Help Therapeutics

INDUSTRY